Showing results (431-440 of 734) with videos related to

Sort By:
Pageof 74
Bone Marrow Transplantation|March 9, 2010
CD34+ cell dose and establishment of full donor chimerism at day +100 are important factors for survival with reduced-intensity conditioning with fludarabine and melphalan before allogeneic hematopoietic SCT for hematologic malignanciesS G Holtan, W J Hogan, M A Elliott, et al.
Transplantation and Cellular Therapy|February 12, 2024
Serial Evaluation of Preimmunization Antibody Titers in Lymphoma Patients Receiving Chimeric Antigen Receptor T Cell TherapyRadhika Bansal, Paschalis Vergidis, Pritish K Tosh, et al.
Cancer Research|April 23, 2009
Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphomaAnne J Novak, Susan L Slager, Zachary S Fredericksen, et al.
Blood|July 15, 2004
Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcomeAnne J Novak, Deanna M Grote, Mary Stenson, et al.
Mayo Clinic Proceedings|April 10, 2003
Posttransplantation thrombotic thrombocytopenic purpura: a single-center experience and a contemporary reviewMichelle A Elliott, William L Nichols, Elizabeth A Plumhoff, et al.
Haematologica|October 14, 2011
Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphomaLuis F Porrata, Kay Ristow, Joseph P Colgan, et al.
Bone Marrow Transplantation|April 25, 2006
Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphomaF K Buadi, I N Micallef, S M Ansell, et al.
American Journal of Clinical Pathology|June 23, 2016
Lymphoplasmacytic Lymphoma With a Non-IgM Paraprotein Shows Clinical and Pathologic Heterogeneity and May Harbor MYD88 L265P MutationsRebecca L King, Wilson I Gonsalves, Stephen M Ansell, et al.
British Journal of Haematology|February 25, 2012
Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in nodular lymphocyte-predominant Hodgkin lymphomaLuis F Porrata, Kay Ristow, Thomas M Habermann, et al.
British Journal of Haematology|April 17, 2007
Absolute lymphocyte count predicts therapeutic efficacy of rituximab therapy in follicular lymphomasDeepti Behl, Kay Ristow, Svetomir N Markovic, et al.
Pageof 74